Copenhagen, Denmark

Søren Jensby Nielsen

This inventor holds 3 USPTO granted patents. Top assignee: Nuevolution A/s. Active years: 2022-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Søren Jensby Nielsen. Retrieved from https://idiyas.com/inventor/søren-jensby-nielsen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.6

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Søren Jensby Nielsen

Introduction

Søren Jensby Nielsen is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that interact with nuclear receptors. With a total of 3 patents to his name, Nielsen's work is recognized for its potential therapeutic applications.

Latest Patents

Nielsen's latest patents include innovative compounds that are active towards nuclear receptors. These patents disclose pharmaceutical compositions containing these compounds and outline their use in therapy. The focus on nuclear receptors highlights the importance of his research in the context of drug development and therapeutic interventions.

Career Highlights

Søren Jensby Nielsen is currently associated with Nuevolution A/S, a company that specializes in drug discovery and development. His role at Nuevolution allows him to leverage his expertise in creating novel pharmaceutical solutions. His work has positioned him as a key figure in the advancement of therapeutic compounds.

Collaborations

Nielsen collaborates with talented professionals in his field, including Sanne Schrøder Glad and Ian Sarvary. These collaborations enhance the innovative capacity of his projects and contribute to the overall success of their research endeavors.

Conclusion

Søren Jensby Nielsen's contributions to the field of pharmaceuticals through his patents and work at Nuevolution A/S demonstrate his commitment to advancing medical science. His innovative approach to developing compounds active towards nuclear receptors holds promise for future therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…